2025-10-13T10:55:44-05:00 2024-12-31 541149263 YOUNT HYDE & BARBOUR PC PO BOX 2560 WINCHESTER VA 226041760 990 2024-01-01 131772100 NATIONAL PHARMACEUTICAL COUNCIL INC NATI 2028272100 1717 PENNSYLVANIA AVENUE NW NO 800 WASHINGTON DC 20006 JOHN MICHAEL O'BRIEN CEO 2028272100 2025-09-22 1 0 OLIVIA A HUTTON CPA P00964688 5406623417 2025-09-22 2024 2025-03-06 01:10:19Z JOHN MICHAEL O'BRIEN 1717 PENNSYLVANIA AVE NW NO 800 WASHINGTON DC 20006 14147403 0 X SEE SCHEDULE O X 1953 NY THE NATIONAL PHARMACEUTICAL COUNCIL (NPC) IS A HEALTH POLICY RESEARCH ORGANIZATION DEDICATED TO THE ADVANCEMENT OF GOOD EVIDENCE AND SCIENCE, AND TO FOSTERING AN ENVIRONMENT IN THE UNITED STATES THAT SUPPORTS MEDICAL INNOVATION. 17 17 16 0 0 0 0 0 9600000 8250000 1354697 1171612 12 101 10954709 9421713 0 0 0 0 4161250 5283552 0 0 0 4939892 5228276 9101142 10511828 1853567 -1090115 23403513 24022903 4783906 6496790 18619607 17526113 TO EXPLORE, DEMONSTRATE AND COMMUNICATE - THROUGH RESEARCH, PARTNERSHIP AND EDUCATION - THE ROLE AND VALUE OF INNOVATIVE BIOPHARMACEUTICALS TO ACHIEVE BETTER PATIENT HEALTH. 0 0 NPC FOCUSES ON RESEARCH DEVELOPMENT, INFORMATION DISSEMINATION, EDUCATION AND COMMUNICATION OF THE CRITICAL ISSUES OF EVIDENCE, INNOVATION AND THE VALUE OF MEDICINES FOR PATIENTS. ALL ACTIVITIES UNDERTAKEN BY NPC RELATED TO THESE FUNCTIONS. 0 0 0 1 0 0 0 0 0 1 0 0 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 29 0 1 16 1 0 0 0 0 1 1 0 0 0 X 17 17 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 0 X NATIONAL PHARMACEUTICAL COUNCIL 2028272100 1717 PENNSYLVANIA AVE NW NO 800 WASHINGTON DC 20006 CHRISTINE MARSH CHAIR 1.00 X X 0 0 0 JAN HANSEN VICE CHAIR 1.00 X X 0 0 0 JEREMY ALLEN DIRECTOR 1.00 X 0 0 0 RICK DUDEK DIRECTOR 1.00 X 0 0 0 PATTY FRITZ DIRECTOR 1.00 X 0 0 0 KEVIN HERN DIRECTOR 1.00 X 0 0 0 RUTH HOFFMAN DIRECTOR 1.00 X 0 0 0 CHRIS LIEBMAN DIRECTOR 1.00 X 0 0 0 CHRIS MANCILL DIRECTOR 1.00 X 0 0 0 TRENT MCLAUGHLIN DIRECTOR 1.00 X 0 0 0 RYAN MUNAFO DIRECTOR 1.00 X 0 0 0 JEN NORTON DIRECTOR 1.00 X 0 0 0 BLASINE PENKOWSKI DIRECTOR 1.00 X 0 0 0 COURTNEY PIRON DIRECTOR 1.00 X 0 0 0 REKHA RAMESH DIRECTOR 1.00 X 0 0 0 JOHN O'BRIEN PRESIDENT, CEO 40.00 X X 1671647 0 46228 KIMBERLY WESTRICH CHIEF STRATEGY OFFICER 40.00 X X 378597 0 45325 KATE ROBINSON DIRECTOR 1.00 X 0 0 0 BRUCE WILSON DIRECTOR 1.00 X 0 0 0 JONATHON CAMPBELL CHIEF SCIENCE OFFICER 40.00 X 548871 0 47575 MICHAEL PRATT CHIEF COMMUNICATIONS OFFIC 40.00 X 374382 0 25537 TANYA BAILEY HEAD OF MEMBERSHIP AND MEE 40.00 X 179799 0 26780 JAMES D MOTYKA RESEARCH ASSOCIATE 40.00 X 142113 0 13527 JULIE PATTERSON SENIOR DIRECTOR AND NPC ENTERPRISE LAB DIRECTOR 40.00 X 217492 0 30328 KATHERINE LOVRO SR. DIRECTOR ALLIANCE DEVELOPMENT 40.00 X 181428 0 14178 TYLER WAGNER ASSOCIATE DIRECTOR OF RESEARCH 40.00 X 149082 0 25683 3843411 0 275161 12 1 1 0 TUFTS MEDICAL CENTER 800 WASHINGTON ST BOX 453 BOSTON MA 02111 RESEARCH 396709 IQVIA INC PO BOX 8500-784290 PHILADELPHIA PA 191784290 RESEARCH 379823 REAL CHEMISTRY PO BOX 23718 NEW YORK NY 10087 RESEARCH AND COMMUNICATIONS 337378 PROJECT HOPE 1220 19TH STREET NW SUITE 800 WASHINGTON DC 20001 RESEARCH 315000 DUKE UNIVERSITY PO BOX 602651 CHARLOTTE NC 282602651 RESEARCH 240000 5 MEMBERSHIP DUES 900099 8250000 8250000 8250000 710150 710150 5187152 4725690 461462 461462 461462 OTHER INCOME 900099 101 101 101 9421713 8250101 0 1171612 2973497 1312032 359326 326362 312335 114518 84515 52062 79775 39024 145049 325667 197449 238375 1293 80236 40367 EXPENDITURES FOR PROJEC 3716233 MISCELLANEOUS 66836 SUBSCRIPTIONS & DUES 46877 10511828 8336692 8285732 268568 283216 62374 59528 986426 1304942 651524 455207 214710 196317 11578325 12231682 1956418 1661486 23403513 24022903 653303 699158 1150000 2965000 2980603 2832632 4783906 6496790 X 18619607 17526113 18619607 17526113 23403513 24022903 -1090115 -3379 0 X 0 1 X 1 0 1 1 0 199688 95684 104004 268263 203086 65177 183573 156437 27136 196317 SECURITY DEPOSITS 26198 LEASE RIGHT OF USE ASSETS 1635288 1661486 NONQUALIFIED, DEFERRED COMPENSATION LIABILITY 690559 LEASE LIABILITIES - NON-CURRENT 2142073 2832632 9366272 -3379 -3379 9369651 52062 52062 9421713 10459766 0 10459766 52062 52062 10511828 1 X X X 0 0 0 JOHN O'BRIEN PRESIDENT, CEO 820713 0 577859 0 273075 0 17250 0 28978 0 1717875 0 0 0 JONATHON CAMPBELL CHIEF SCIENCE OFFICER 427500 0 121128 0 243 0 17250 0 30325 0 596446 0 0 0 KIMBERLY WESTRICH CHIEF STRATEGY OFFICER 293900 0 84000 0 697 0 15000 0 30325 0 423922 0 0 0 MICHAEL PRATT CHIEF COMMUNICATIONS OFFIC 290600 0 83636 0 146 0 14935 0 10602 0 399919 0 0 0 JULIE PATTERSON SENIOR DIRECTOR AND NPC ENTERPRISE L 185025 0 32321 0 146 0 9506 0 20822 0 247820 0 0 0 TANYA BAILEY HEAD OF MEMBERSHIP AND MEE 138417 0 40205 0 1177 0 7251 0 19529 0 206579 0 0 0 KATHERINE LOVRO SR. DIRECTOR ALLIANCE DEVELOPMENT 156795 0 24514 0 119 0 7083 0 7095 0 195606 0 0 0 TYLER WAGNER ASSOCIATE DIRECTOR OF RESEARCH 128900 0 20085 0 97 0 6695 0 18988 0 174765 0 0 0 JAMES D MOTYKA RESEARCH ASSOCIATE 126800 0 15216 0 97 0 6340 0 7187 0 155640 0 0 0 FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS REVIEWED BY THE TREASURER AND THE CHIEF OPERATING OFFICER PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST POLICY COVERS ALL MEMBERS OF THE BOARD, THE OFFICERS, AND STAFF AND IS MONITORED BY ANNUAL WRITTEN INFORMATION QUESTIONNAIRES FROM THE COO AND SENIOR VP WHICH ARE REVIEWED AND MAINTAINED BY THE COO AND SENIOR VP. THE BOARD OFFICERS REVIEW EACH ISSUE TO COME BEFORE THE BOARD FOR POTENTIAL OR ACTUAL CONFLICTS OF INTEREST. IF ANY POTENTIAL OR ACTUAL CONFLICTS ARE IDENTIFIED THE PERSON DETERMINED TO HAVE A CONFLICT IS RECUSED FROM DELIBERATIONS, VOTING OR ANY ACTIONS RELATED TO THE MATTER. THE IDENTIFIED CONFLICTS WOULD BE DOCUMENTED IN THE MINUTES OF EACH BOARD OR COMMITTEE MEETING IF AN OFFICAL VOTE WAS TAKEN. FORM 990, PART VI, SECTION B, LINE 15 THE CHAIRMAN OF THE BOARD REVIEWS AND APPROVES THE SALARY FOR THE PRESIDENT. THE PRESIDENT AND CEO REVIEWS AND APPROVES ALL OTHERS WITHIN THE BUDGET. ALL SALARIES WERE APPROVED IN 2024. FORM 990, PART VI, SECTION C, LINE 19 THE NATIONAL PHARMACEUTICAL COUNCIL DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC.